The group is most interested in similar pharmaceutical companies or companies that can provide a good production capacity with EU GMP. Preference is a company with a market penetration in order to provide cannabis products to patients around the world.
This pharmaceutical group has been pioneering Pharma-Grade cannabis for more than 12 years. The company has provided more than 750,000 doses to 20,000 patients, establishing its position as a venerable player in this global industry. Their products are held to the highest pharmaceutical standards, meeting global Good Manufacturing Practice (GMP) regulatory requirements.
Contact us to get details about this buyer of medical cannabis companies now
The buyer is now looking for a company with products that provide pharma-grade cannabis manufacturing.
The goal of the buyer is to acquire a profitable manufacturing pharma company with revenue in the range of 3 – 30 million euro.
Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual please explain as much as possible about your personal background strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.